785 related articles for article (PubMed ID: 12672909)
21. Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).
Dasch B; Fuhs A; Schmidt J; Behrens T; Meister A; Wellmann J; Fobker M; Pauleikhoff D; Hense HW
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1028-35. PubMed ID: 15909159
[TBL] [Abstract][Full Text] [Related]
22. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys.
Johnson EJ; Neuringer M; Russell RM; Schalch W; Snodderly DM
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):692-702. PubMed ID: 15671301
[TBL] [Abstract][Full Text] [Related]
23. Lutein, zeaxanthin, and the macular pigment.
Landrum JT; Bone RA
Arch Biochem Biophys; 2001 Jan; 385(1):28-40. PubMed ID: 11361022
[TBL] [Abstract][Full Text] [Related]
24. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
[TBL] [Abstract][Full Text] [Related]
25. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
Nolan JM; Stack J; O'connell E; Beatty S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
[TBL] [Abstract][Full Text] [Related]
26. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
Zeimer M; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Ophthalmologe; 2009 Jan; 106(1):29-36. PubMed ID: 18551295
[TBL] [Abstract][Full Text] [Related]
27. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
[TBL] [Abstract][Full Text] [Related]
28. Associations between lutein, zeaxanthin, and age-related macular degeneration: an overview.
Carpentier S; Knaus M; Suh M
Crit Rev Food Sci Nutr; 2009 Apr; 49(4):313-26. PubMed ID: 19234943
[TBL] [Abstract][Full Text] [Related]
29. The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.
Khachik F; de Moura FF; Chew EY; Douglass LW; Ferris FL; Kim J; Thompson DJ
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5234-42. PubMed ID: 17122108
[TBL] [Abstract][Full Text] [Related]
30. Effect of dietary zeaxanthin on tissue distribution of zeaxanthin and lutein in quail.
Toyoda Y; Thomson LR; Langner A; Craft NE; Garnett KM; Nichols CR; Cheng KM; Dorey CK
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1210-21. PubMed ID: 11923268
[TBL] [Abstract][Full Text] [Related]
31. Plasma kinetics of zeaxanthin and 3'-dehydro-lutein after multiple oral doses of synthetic zeaxanthin.
Hartmann D; Thürmann PA; Spitzer V; Schalch W; Manner B; Cohn W
Am J Clin Nutr; 2004 Mar; 79(3):410-7. PubMed ID: 14985215
[TBL] [Abstract][Full Text] [Related]
32. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
33. Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene.
Wang Y; Roger Illingworth D; Connor SL; Barton Duell P; Connor WE
Eur J Nutr; 2010 Sep; 49(6):327-36. PubMed ID: 20082082
[TBL] [Abstract][Full Text] [Related]
34. Macular pigment and its contribution to vision.
Loskutova E; Nolan J; Howard A; Beatty S
Nutrients; 2013 May; 5(6):1962-9. PubMed ID: 23760061
[TBL] [Abstract][Full Text] [Related]
35. The macular xanthophylls.
Ahmed SS; Lott MN; Marcus DM
Surv Ophthalmol; 2005; 50(2):183-93. PubMed ID: 15749308
[TBL] [Abstract][Full Text] [Related]
36. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population.
Beatty S; Murray IJ; Henson DB; Carden D; Koh H; Boulton ME
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):439-46. PubMed ID: 11157880
[TBL] [Abstract][Full Text] [Related]
37. Interrelationships between maternal carotenoid status and newborn infant macular pigment optical density and carotenoid status.
Henriksen BS; Chan G; Hoffman RO; Sharifzadeh M; Ermakov IV; Gellermann W; Bernstein PS
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5568-78. PubMed ID: 23838770
[TBL] [Abstract][Full Text] [Related]
38. Fasting plasma zeaxanthin response to Fructus barbarum L. (wolfberry; Kei Tze) in a food-based human supplementation trial.
Cheng CY; Chung WY; Szeto YT; Benzie IF
Br J Nutr; 2005 Jan; 93(1):123-30. PubMed ID: 15705234
[TBL] [Abstract][Full Text] [Related]
39. Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail.
Thomson LR; Toyoda Y; Delori FC; Garnett KM; Wong ZY; Nichols CR; Cheng KM; Craft NE; Dorey CK
Exp Eye Res; 2002 Nov; 75(5):529-42. PubMed ID: 12457865
[TBL] [Abstract][Full Text] [Related]
40. A review of the evidence germane to the putative protective role of the macular carotenoids for age-related macular degeneration.
Sabour-Pickett S; Nolan JM; Loughman J; Beatty S
Mol Nutr Food Res; 2012 Feb; 56(2):270-86. PubMed ID: 22121091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
